Pharma Mar, S.A. / Financial strength (Piotroski F-Value)

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    Financial strength (Piotroski F-Value)
    6 / 9
    Return on assets (ROA) greater than 0
    check 12.1%
    Operating cash flow greater than 0
    check $8.80M
    ROA greater than previous year
    check 12.1% > -0.6%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    close 2.5% ≤ 12.1%
    Leverage ratio lower than previous year
    close 11.2% ≥ 8.6%
    Current ratio greater than previous year
    check 284.1% > 255.0%
    No new common stock issued last year
    close $18.24M
    Gross margin greater than previous year
    check 95.0% > 93.4%
    Asset turnover greater than previous year
    check 54.3% > 50.1%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    2
    2
    1
    1
    2
    2
    3
    3
    2
    2
    2
    1
    7
    7
    7
    8
    7
    4
    4
    4
    5
    6
    6
    4
    3
    4
    2
    2
    3
    1
    6
    6
    5
    6

    Notifications